title: Ethical issues in funding orphan drug research and development.
abstract: This essay outlines the moral dilemma of funding orphan drug research and development. To date, ethical aspects of priority setting for research funding have not been an issue of discussion in the bioethics debate. Conflicting moral obligations of beneficence and distributive justice appear to demand very different levels of funding for orphan drug research. The two types of orphan disease, rare diseases and tropical diseases, however, present very different ethical challenges to questions about allocation of research funds. The dilemma is analysed considering utilitarian and rights based theories of justice and moral obligations of non-abandonment and a professional obligation to advance medical science. The limitations of standard economic evaluation tools and other priority setting tools used to inform health policy decision makers on research funding decisions are outlined.
authors.affiliation: Department of Health Care Management, Technische Universität Berlin, Strasse des 17. Juni 145, D-10623 Berlin. christian.gericke@tu-berlin.de
authors.forename: C A
authors.initials: CA
authors.lastname: Gericke
authors.forename: A
authors.initials: A
authors.lastname: Riesberg
authors.forename: R
authors.initials: R
authors.lastname: Busse
mesh_terms: D004341:Drug Evaluation / Q000191:economics*; D004994:Ethics, Pharmacy; D006801:Humans; D009014:Morals; D009965:Orphan Drug Production; D010601:Pharmacology, Clinical / Q000191:economics / Q000941:ethics*; D012106:Research; D012109:Research Support as Topic / Q000941:ethics*
references.citation: J Med Ethics. 2000 Oct;26(5):323-9
references.pmid: 11055033
references.citation: Health Technol Assess. 2001;5(3):1-138
references.pmid: 11207451
references.citation: Rev Epidemiol Sante Publique. 2001 Sep;49(4):387-96
references.pmid: 11567205
references.citation: Philos Public Aff. 1997 Fall;26(4):303-50
references.pmid: 11660435
references.citation: Nature. 2003 May 15;423(6937):343-8
references.pmid: 12748653
references.citation: BMJ. 2000 Sep 30;321(7264):824-6
references.pmid: 11009528
references.citation: BMJ. 1994 Jul 16;309(6948):184-8
references.pmid: 8044100
references.citation: Health Care Manage Rev. 1998 Fall;23(4):43-53
references.pmid: 9803318
references.citation: Bull World Health Organ. 1998;76 Suppl 2:147-9
references.pmid: 10063699
references.citation: J Med Ethics. 1999 Jun;25(3):224-9
references.pmid: 10390676
references.citation: J Health Econ. 1991 Jul;10(2):107-42
references.pmid: 10113009